About Jeffrey Port
Jeffrey Port is a founder & chairman at TMRW Life Sciences.
Form D filings also name Jeffrey Port as a director at Angiocrine Bioscience.
Jeffrey Port first appears on SEC filings in 2019.
Experience
This experience comes from Jeffrey Port's profile and from SEC filings. For roles taken from filings, the years are when the filings name Jeffrey Port in the role, so the role may have started earlier or lasted longer.
TMRW Life Sciences, Inc. Current
Founder & Chairman
2017 – Present · New York, NY
TMRW sells frozen specimen storage and tracking systems to fertility clinics.
WM
Weill Cornell Medicine Current
Professor of Cardiothoracic Surgery
1998 – Present
Key Colleagues at Startups
The people Jeffrey Port works with at each company, as listed on that company's latest Form D.
TMRW Life Sciences, Inc. · Form D, Apr 24, 2026
Andrew Schwab
Founder & Managing Partner, 5AM Ventures, director
EC
Emily Drabant Conley
Director
LV
Louis Villalba
Chief Executive Officer and director
Vinay Shah
Investor, Transformation Capital and director
WS
William Schoolcraft
Director
GE
Greg Eisner
Director
Angiocrine Bioscience, Inc. · Form D, Sep 5, 2025
DP
David Parkinson
Director
JL
John Lomoro
Chief Financial Officer/Treasurer
PF
Paul Finnegan
President/Chief Executive Officer and director
JJ
John Jaskowiak
Chief Operating Officer/Secretary